Price Alert

Revelation Biosciences In... (REVB)

NASDAQ: REVB · Real-Time Price · USD

2.57

-0.01 (-0.39%)

At close: Aug 15, 2025, 3:51 PM

2.60

1.33%

After-hours: Aug 15, 2025, 07:36 PM EDT

Revelation Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	5.17M	3.7M	6.5M	6.54M	12.07M	14.55M	11.99M	13.99M	15.71M	17.7M	5.25M	6.2M	3.48M	7.19M	1.27M	4.14M	73.51M	73.51M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	19.75K	n/a	390.65K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	48.3M	73.52M	73.51M	73.51M
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-48.3M	-73.52M	-187.62K	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	186.05K	223.27K	49.5K	74.85K	56.95K	67.98K	100.61K	81.39K	107.51K	118.64K	160.3K	n/a	n/a	n/a	148.73K	n/a	-73.51M	-73.51M
Total Current Assets	5.36M	3.93M	6.57M	6.66M	12.2M	14.62M	12.15M	14.15M	15.96M	18.04M	5.41M	6.51M	4.05M	7.87M	1.91M	5.7M	373.64K	515.16K
Property-Plant & Equipment	35.17K	42.39K	56.33K	81.24K	70.77K	77.99K	65.08K	71.35K	77.61K	83.87K	90.13K	96.39K	102.66K	108.92K	130.14K	167.2K	187.62K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	35.17K	42.39K	56.33K	81.24K	70.77K	77.99K	65.08K	71.35K	77.61K	83.87K	90.13K	96.39K	102.66K	108.92K	130.14K	167.2K	73.51M	73.51M
Total Assets	5.4M	3.97M	6.62M	6.74M	12.27M	14.7M	12.21M	14.22M	16.04M	18.12M	5.5M	6.6M	4.15M	7.98M	2.04M	5.87M	73.89M	74.03M
Account Payables	828.89K	625.06K	783.62K	3.13M	1.28M	1.68M	1.36M	1.26M	913.87K	705.09K	554.21K	466.08K	916.48K	1.46M	596.26K	1.03M	907.05K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.91M	n/a	n/a	2.91M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.75K	n/a	n/a	n/a
Other Current Liabilities	336.32K	464.46K	2.25K	4.8K	9.39M	3.3M	3.44M	723.93K	3.38M	6.69M	367.48K	3.23M	4.1M	5.64M	-16.75K	n/a	2.41M	2.12M
Total Current Liabilities	1.57M	1.09M	1.91M	4.07M	11.13M	5.23M	5.56M	5.4M	4.62M	8.1M	4.45M	4.37M	6M	8.08M	2.14M	2.21M	3.31M	2.12M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.91M	n/a	2.91M	2.91M
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	554.21K	466.08K	916.48K	1.46M	2.91M	n/a	2.91M	2.91M
Total Liabilities	1.57M	1.09M	1.91M	4.07M	11.13M	5.23M	5.56M	5.4M	4.62M	8.1M	4.45M	4.37M	6M	8.08M	2.14M	2.21M	6.22M	5.03M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.75K	33.02K	n/a	n/a
Common Stock	1.53K	964.00	522.00	4.29K	1.64K	1.63K	265.00	6.3K	6.3K	4.73K	683.00	23.54K	15.08K	15.08K	282.00	2.31K	73.51M	73.51M
Retained Earnings	-45M	-42.56M	-40.51M	-38.78M	-36.54M	-28.15M	-25.47M	-23.26M	-20.64M	-19.19M	-25.35M	-24.14M	-22.97M	-21.13M	-14.52M	-10.66M	-5.85M	-4.52M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	3.83M	2.88M	4.71M	2.67M	1.14M	9.47M	6.65M	8.82M	11.41M	10.02M	1.05M	2.23M	-1.84M	-98.51K	-99.47K	3.66M	67.66M	69M
Total Investments	n/a	n/a	6.49B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	48.3M	73.54M	73.82M	73.9M